Integrated Filing-Governance



General information about company

Scrip Code 543427
NSE Symbol MEDPLUS
MSEI Symbol NOTLISTED
ISIN INE804L01022
Name of the entity MEDPLUS HEALTH SERVICES LIMITED
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Reporting Quarter Yearly
Date of Quarter Ending 31-Mar-2026
Type of company Equity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity? Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity? Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity? No
Reason For Part C Of Annexure I Disclosure Of Acquisition Of Shares OrVotingRightsInUnlistedCompaniesIsNotApplicableToTheEntity There is no acquisition of Shares or Voting Rights in unlisted Company during the Quarter.
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity? Yes
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity? Yes
Whether Annexure I (Part F) of the SEBI Circular dated December 31, 2024 related to Disclosure Of Loans / Guarantees / Comfort Letters / Securities Etc. is Applicable to the entity? Yes
Risk management committee Yes
Market Capitalisation as per immediate previous Financial Year Top 1000 listed entities
Is SCORE ID Available ? Yes
SCORE Registration ID M00915
Reason For No SCORE ID
Type of Submission New
Remarks (website dissemination)



Annexure I
Annexure I to be submitted by listed entity on quarterly basis
I. Composition of Board of Directors
Disclosure of notes on composition of board of directors explanatory
Whether the listed entity has a Regular Chairperson Yes
Whether Chairperson is related to MD or CEO Yes Disqualification of Directors under section 164 of the Companies Act, 2013
Sr Title (Mr / Ms) Name of the Director PAN DIN Category 1 of directors Category 2 of directors Category 3 of directors Date of Birth Whether the director is disqualified? Start Date of disqualification End Date of disqualification Details of disqualification Current status Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations] Date of passing special resolution Initial Date of appointment Date of Re-appointment Date of cessation Tenure of director (in months) No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations) No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & 17A(2)] Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations) No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations) Reason for Cessation Notes for not providing PAN Notes for not providing DIN
1 Mr. Gangadi Madhukar Reddy 00098097 Executive Director Chairperson related to Promoter CEO-MD 20-Sep-1967 No Active NA 30-Nov-2006 03-Aug-2021 1 0 2 0
2 Mr. Madhavan Ganesan 01674529 Non-Executive - Independent Director Not Applicable 07-Sep-1964 No Active NA 11-Jun-2021 11-Jun-2021 57.2 3 2 5 1
3 Mr. Murali Sivaraman 01461231 Non-Executive - Independent Director Not Applicable 21-Apr-1961 No Active NA 11-Jun-2021 11-Jun-2021 57.2 5 5 7 3
4 Ms. Aparna Surabhi 01641633 Non-Executive - Independent Director Not Applicable 20-Aug-1967 No Active NA 01-Jul-2024 01-Jul-2024 21 3 3 6 4
5 Mr. Cherukupalli Bhaskar Reddy 00926550 Executive Director Not Applicable 13-Jun-1968 No Active NA 26-Oct-2023 1 0 2 0
6 Mr. Muralidharan Thyagarajan 00052097 Non-Executive - Independent Director Not Applicable 20-Jul-1957 No Active NA 18-Dec-2024 18-Dec-2024 15.13 1 1 0 0



Annexure 1

II. Composition of Committees
Disclosure of notes on composition of committees explanatory



Audit Committee Details
Whether the Audit Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 01461231 Murali Sivaraman Non-Executive - Independent Director Chairperson 05-Jul-2021
2 01641633 Aparna Surabhi Non-Executive - Independent Director Member 12-Jul-2024
3 01674529 Madhavan Ganesan Non-Executive - Independent Director Member 05-Jul-2021



Nomination and remuneration committee
Whether the Nomination and remuneration committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00052097 Muralidharan Thyagarajan Non-Executive - Independent Director Chairperson 27-May-2025
2 01461231 Murali Sivaraman Non-Executive - Independent Director Member 05-Jul-2021
3 01674529 Madhavan Ganesan Non-Executive - Independent Director Member 05-Jul-2021
4 01641633 Aparna Surabhi Non-Executive - Independent Director Member 12-Jul-2024



Stakeholders Relationship Committee
Whether the Stakeholders Relationship Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 01674529 Madhavan Ganesan Non-Executive - Independent Director Chairperson 05-Jul-2021
2 00098097 Gangadi Madhukar Reddy Executive Director Member 22-Dec-2023
3 00926550 Cherukupalli Bhaskar Reddy Executive Director Member 12-Jul-2024



Risk Management Committee
Whether the Risk Management Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 01674529 Madhavan Ganesan ID Chairperson 05-Jul-2021
2 01641633 Aparna Surabhi ID Member 12-Jul-2024
3 01461231 Murali Sivaraman ID Member 08-Nov-2023
4 00098097 Gangadi Madhukar Reddy ED Member 05-Jul-2021
5 00926550 Cherukupalli Bhaskar Reddy ED Member 08-Nov-2023
6 00052097 Muralidharan Thyagarajan ID Member 27-May-2025



Annexure 1
III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory
Sr Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Notes for not providing Date Whether requirement of Quorum met (Yes/No) Total Number of Directors as on date of the meeting Number of Directors present* (All directors including Independent Director) No. of Independent Directors attending the meeting*
1 31-Oct-2025 Yes 6 6 4
2 30-Jan-2026 90 Yes 6 6 4
3 16-Mar-2026 44 Yes 6 6 4



Annexure 1
IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory
Sr Name of Committee Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Name of other committee Reson for not providing date Whether requirement of Quorum met (Yes/No) Total Number of Directors in the Committee as on date of the meeting Number of Directors Present (All Directors including Independent Director) No. of Independent Directors attending the meeting* No. of members attending the meeting (other than Board of Directors)
1 Audit Committee 31-Oct-2025 Yes 3 3 3 0
2 Audit Committee 30-Jan-2026 90 Yes 3 3 3 0
3 Risk Management Committee 20-Dec-2025 Yes 6 6 4 0
4 Nomination and remuneration committee 30-Jan-2026 Yes 4 4 4 0



Annexure 1
VI. Affirmations
Sr Subject Compliance status (Yes/No)
1 The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
2 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee Yes
3 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee Yes
4 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee Yes
5 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities) Yes
6 The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. Yes
7 The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
8 This report and/or the report submitted in the previous quarter has been placed before Board of Directors. Yes
9 Any comments/observations/advice of Board of Directors may be mentioned here:



Annexure 1
Sr Subject Compliance status
1 Name of signatory Manoj Kumar Srivastava
2 Designation Company Secretary and Compliance Officer



Details of Cyber security incidence
Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter No
Other details of cyber security incidence or breaches or loss of data event
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr Date of the event Brief details of the event



Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)
I. Disclosure on website in terms of LODR Regulation
Sr Item Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here. Web address
1.1 Details of business Yes https://www.medplusindia.com/our-businesses.jsp
1.2 Memorandum of Association and Articles of Association Yes https://www.medplusindia.com/corporate.jsp
1.3 Brief profile of board of directors including directorship and full time positions in body corporates Yes https://www.medplusindia.com/corporate.jsp
2 Terms and conditions of appointment of independent directors Yes https://www.medplusindia.com/uploads/content/Terms%20and%20Conditions%20of%20Appointment%20of%20Independent%20Directors.pdf
3 Composition of various committees of board of directors Yes https://www.medplusindia.com/uploads/content/Composition%20of%20Board%20and%20Committees.pdf
4 Code of conduct of board of directors and senior management personnel Yes https://www.medplusindia.com/uploads/content/Code%20of%20Conduct%20for%20Directors%20and%20Senior%20Management.pdf
5 Details of establishment of vigil mechanism or whistle blower policy Yes https://www.medplusindia.com/uploads/content/Whistle%20Blower%20Policy.pdf
6 Criteria of making payments to non-executive directors Yes https://www.medplusindia.com/uploads/content/Nomination%20and%20Remuneration%20Policy.pdf
7 Policy on dealing with related party transactions Yes https://www.medplusindia.com/uploads/content/Policy%20on%20Materiality%20of%20and%20dealing%20with%20Related%20Party%20Transactions.pdf
8 Policy for determining material subsidiaries Yes https://www.medplusindia.com/uploads/content/Policy%20on%20Material%20Subsidiary.pdf
9 Details of familiarization programmes imparted to independent directors Yes https://www.medplusindia.com/corporate.jsp
10 Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances Yes https://www.medplusindia.com/corporate.jsp
11 Email address for grievance redressal and other relevant details Yes cs@medplusindia.com
12 Financial results Yes https://www.medplusindia.com/corporate.jsp
13 Shareholding pattern Yes https://www.medplusindia.com/corporate.jsp
14 Details of agreements entered into with the media companies and/or their associates NA
15.1 Schedule of analyst or institutional investor meet and presentation prepared by listed entity for analyst or institutional investor meet Yes https://www.medplusindia.com/corporate.jsp
15.2 Audio or video recordings and transcripts of post earnings/quarterly calls Yes https://www.medplusindia.com/corporate.jsp
16 New name and the old name of the listed entity NA
17 Advertisements as per regulation 47 (1) Yes https://www.medplusindia.com/corporate.jsp
18 Credit rating or revision in credit rating obtained NA
19 Separate audited financial statements of each subsidiary of the listed entity Yes https://www.medplusindia.com/corporate.jsp
20 Secretarial compliance report Yes https://www.medplusindia.com/corporate.jsp
21 Materiality policy as per regulation 30 (4) Yes https://www.medplusindia.com/uploads/content/Policy%20on%20Materiality.pdf
22 Disclosure of contact details of KMP who are authorized for the purpose of determining materiality as required under regulation 30(5) Yes https://www.medplusindia.com/corporate.jsp
23 Disclosures under regulation 30(8) Yes https://www.medplusindia.com/corporate.jsp
24 Statements of deviation(s) or variations(s) as specified in regulation 32 Yes https://www.medplusindia.com/corporate.jsp
25 Dividend distribution policy as specified in regulation 43A (1) Yes https://www.medplusindia.com/uploads/content/Policy-on-Dividend-Distribution.pdf
26.1 Annual return as provided under section 92 of the Companies Act 2013 Yes https://www.medplusindia.com/uploads/content/MedPlus_Draft_Form_MGT_7_Annual_Return_FY2024-25.pdf
26.2 Employee benefit scheme documents framed in terms of SEBI (SBEB) regulations 2021
27 Confirmation that the above disclosures are in a separate section as specified in regulation 46(2) Yes https://www.medplusindia.com/corporate.jsp
28 Compliance with regulation 46(3) with respect to accuracy of disclosures on the website and timely updation Yes https://www.medplusindia.com/corporate.jsp
29 Disclosure of notes on website in terms of Listing Regulations explanatory


Annexure II
II. Annual Affirmations
Sr Particulars Regulation Number Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here.
1 Independent director(s) have been appointed in terms of specified criteria of independence and/or eligibility 16(1)(b) Yes
2 Board Composition 17(1), 17(1A) & 17(1C), 17(1D) & 17(1E) Yes
3 Meeting Of Board Of Directors 17(2) Yes
4 Quorum of board meeting 17(2A) Yes
5 Review of Compliance Reports 17(3) Yes
6 Plans for orderly succession for appointments 17(4) Yes
7 Code of Conduct 17(5) Yes
8 Fees/compensation 17(6) Yes
9 Minimum Information 17(7) Yes
10 Compliance Certificate 17(8) Yes
11 Risk Assessment & Management 17(9) Yes
12 Performance Evaluation of Independent Directors 17(10) Yes
13 Recommendation of Board 17(11) Yes
14 Maximum number of Directorships 17A Yes
15 Composition of Audit Committee 18(1) Yes
16 Meeting of Audit Committee 18(2) Yes
17 Role of Audit Committee and information to be reviewed by the audit committee 18(3) Yes
18 Composition of nomination & remuneration committee 19(1) & (2) Yes
19 Quorum of Nomination and Remuneration Committee meeting 19(2A) Yes
20 Meeting of Nomination and Remuneration Committee 19(3A) Yes
21 Role of Nomination and Remuneration Committee 19(4) Yes
22 Composition of Stakeholder Relationship Committee 20(1), 20(2) & 20(2A) Yes
23 Meeting of Stakeholders Relationship Committee 20(3A) Yes
24 Role of Stakeholders Relationship Committee 20(4) Yes
25 Composition and role of risk management committee 21(1),(2),(3),(4) Yes
26 Meeting of Risk Management Committee 21(3A) Yes
27 Quorum of Risk Management Committee meeting 21(3B) Yes
28 Gap between the meetings of the Risk Management Committee 21(3C) Yes
29 Vigil Mechanism 22 Yes
30 Policy for related party Transaction 23(1), (1A), (5), (6), & (8) Yes
31 Prior or Omnibus approval of Audit Committee for all related party transactions 23(2), (3) Yes
32 Approval for material related party transactions 23(4) Yes
33 Disclosure of related party transactions on consolidated basis 23(9) Yes
34 Composition of Board of Directors of unlisted material Subsidiary 24(1) Yes
35 Other Corporate Governance requirements with respect to subsidiary of listed entity 24(2),(3),(4),(5) & (6) Yes
36 Alternate Director to Independent Director 25(1) NA
37 Maximum Tenure 25(2) Yes
38 Appointment, Re-appointment or removal of an Independent Director through special resolution or the alternate mechanism 25(2A) NA
39 Meeting of independent directors 25(3) & (4) Yes
40 Familiarization of independent directors 25(7) Yes
41 Declaration from Independent Director 25(8) & (9) Yes
42 Directors and Officers insurance 25(10) Yes
43 Confirmation with respect to appointment of Independent Directors who resigned from the listed entity 25(11) NA
44 Memberships in Committees 26(1) Yes
45 Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel 26(3) Yes
46 Policy with respect to Obligations of directors and senior management 26(2) & 26(5) Yes
47 Approval of the Board and shareholders for compensation or profit sharing in connection with dealings in the securities of the listed entity 26(6) NA
48 Vacancies in respect Key Managerial Personnel 26A(1) & 26A(2), 26A(3) NA
Any other information to be provided - Add Notes



Annexure II
III. Affirmations
Sr Particulars Compliance status (Yes/No/NA)
1 The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been complied Yes
Any other information to be provided



Annexure II
1 Name of signatory Manoj Kumar Srivastava
2 Designation Company Secretary and Compliance Officer



Additional Half yearly Disclosure
Any Other Information for Disclosure of Loans / Guarantees / Comfort Letters / Securities Etc.
I. Disclosure of Loans/ guarantees/comfort letters /securities etc.refer note below
(A)Any loan or any other form of debt advanced by the listed entity directly or indirectly to
Entity Aggregate amount advanced during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them 0 0
Promoter Group or any other entity controlled by them 0 0
Directors (including relatives) or any other entity controlled by them 0 0
KMPs or any other entity controlled by them 0 0
(B) Any guarantee / comfort letter (by whatever name called) provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed By
Entity Type (guarantee, comfort letter etc.) Aggregate amount of issuance during six months Balance outstanding at the end of six months(taking into account any invocation)
Promoter or any other entity controlled by them 0 0 0
Promoter Group or any other entity controlled by them 0 0 0
Directors (including relatives) or any other entity controlled by them 0 0 0
KMPs or any other entity controlled by them 0 0 0
(C) Any security provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed by
Entity Type of security (cash, shares etc.) Aggregate value of security provided during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them 0 0 0
Promoter Group or any other entity controlled by them 0 0 0
Directors (including relatives) or any other entity controlled by them 0 0 0
KMPs or any other entity controlled by them 0 0 0
(D) Additional Information
II. Affirmations
Affirmations Compliance Status Company Remarks
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company. Yes
Name Sujit Kumar Mahato
Designation CEO
Place Hyderabad
Date 27-Apr-2026



Signatory Details
Name of signatory Manoj Kumar Srivastava
Designation of person Company Secretary and Compliance Officer
Place Hyderabad
Date 27-Apr-2026


Investor Grievance Details
No. of investor complaints pending at the beginning of Quarter 0
No. of investor complaints received during the Quarter 0
No. of investor complaints disposed off during the Quarter 0
No. of investor complaints those remaining unresolved at the end of the Quarter 0


Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies-
The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below
Any Other Information for Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies
Sr. No. Name of the unlisted company in which shares or voting rights have been acquired Date of acquisition Aggregate holding (% shares or voting rights) as at the end of the previous quarter % shares or voting rights acquired during the quarter Aggregate holding (% shares or voting rights) as at the end of the quarter


Disclosure of Imposition of Fine or Penalty
The details of imposition of fine or penalty during the quarter in terms of sub-para 20 of para A of Part A of Schedule III are given below:
Any Other Information for Disclosure of Imposition of Fine or Penalty
Sr. No. Name of the authority Nature and details of the action(s) taken or order(s) passed Date of receipt of direction or order, including any ad interim or interim orders, or any other communication from the authority Details of the violation(s)/ contravention(s) committed or alleged to be committed Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible
1 Dy, Assistant Commissioner (ST), Vishakapatnam, AP Paid Rs.150000/- against Vehicle detained by GST officer during movement 02-Jan-2026 Vehicle detained by Dy, Assistant Commissioner (ST), Vishakapatnam (AP) during the movement of vehicle alleging that failure to prove proper documents while moving the goods to one place to another. There is no material impact on financial, operations or other activities of the Company
2 Adjudication officer and Joint Commissioner (Food), Amravati Division, Food and Drug administration, Amravati Order passed / action taken penalty of Rs. 50000/- 20-Jan-2026 Violation of Section 52 and 53 of Food Safety and Standards Act, 2006. The Company has made the requisite payment on 20/01/2026. There is no material impact on financial, operations or other activities of the Company
3 Special Court for Economic Offences, Bangaluru Order passed / action taken penalty of Rs. 75000/- for sale of substitute medicine. 13-Jan-2026 Drugs & Cosmetic Act, 1940 There is no material impact on financial, operations or other activities of the Company
4 Assistant State Tax Officer, Enforcement squad, Alapuzha, Kerala Paid Rs.54000/-against Vehicle detained by GST officer during movement 28-Jan-2026 Vehicle detained by Assistant State Tax Officer, Enforcement squad, Alapuzha, Kerala during the movement of vehicle alleging that failure to prove proper documents while moving the goods to one place to another. There is no material impact on financial, operations or other activities of the Company
5 Dy Commercial Tax Officer, Peddapalli, Karimnagar Dvn Paid Rs.100000/- against Vehicle detained by GST officer during movement 29-Jan-2026 Vehicle detained by Dy Commercial Tax Officer, Peddapalli, Karimnagar Dvn during the movement of vehicle alleging that failure to prove proper documents while moving the goods to one place to another. There is no material impact on financial, operations or other activities of the Company
6 JMFC IV Court, Belagavi Belgaum Paid Rs.60,000/- for Sale of H1 medicine in the absence of Qualified Pharmacist. 03-Feb-2026 Section 27(d) of the Drugs & Cosmetic Act, 1940 There is no material impact on financial, operations or other activities of the Company
7 Judicial Magistrate (First Class) 42nd Court at Shindewadi Dadar, Mumbai Paid Rs.16,000/-for Carrying on the trade of Chemist & Drug Medical Store without Health license under Section 394/471 of the M.M.C. Act, 1888 18-Feb-2026 Section 394/471 of the M.M.C. Act, 1888 There is no material impact on financial, operations or other activities of the Company
8 PRL Civil Judge and JMFC Udupi Paid Rs.60,000/- for Sale of H1 drugs without prescription 12-Mar-2026 Violation of section 18(a)(iv) read with Rule 65 (9)(a) and pnishable under Section 27(d) of the Drugs & Cosmetic Act, 1940 There is no material impact on financial, operations or other activities of the Company
9 Adjudication officer and Joint Commissioner (Food), Amravati Division, Food and Drug administration, Amravati Order passed / action taken penalty of Rs. 50000/- 20-Jan-2026 Violation of Section 52 and 53 of Food Safety and Standards Act, 2006. The Company has made the requisite payment on 20/01/2026. There is no material impact on financial, operations or other activities of the Company
10 Assistant Director, Drugs control Administration, Gagad Circle Gadag,Karnataka Suspension of drug license for 1 days 02-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
11 Assistant Director, Drugs Control Administration, Madikeri Circle, Madikeri,Karnataka Suspension of drug license for 2 days 10-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
12 Assistant Director, Drugs Control Administration, Bangalore Circle-2, Bangalore,Karnataka Suspension of drug license for 2 days 10-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
13 Assistant Director, Drugs Control Administration, Bangalore Circle-2, Bangalore,Karnataka Suspension of drug license for 2 days 10-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
14 Assistant Director, Drugs Control Administration, Bangalore Circle-2, Bangalore,Karnataka Suspension of drug license for 2 days 10-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
15 Assistant Director, Drugs Control Administration, Bangalore Circle-2, Bangalore,Karnataka Suspension of drug license for 2 days 10-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
16 The Assistant Director, Drugs Control Administration, Nalgonda,Telangana Suspension of drug license for 04 days from the date of receipt of order for sales premises. 12-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
17 Assistant Director,� Drugs Control Administration, PATANCHERUVU,Telangana Suspension of drug license for 1 day from the date of receipt of order for sales premises 12-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
18 Asst. Commissioner & Licensing authority, Food & Drug Administations, MH, Bhandara,Maharashtra. Suspension of Drug License for 5 days from 15.04.2026 to 19.04.2026 13-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
19 Assistant Director, Drugs Control Administration, Karwar circle Karwar,Karnataka Suspension of Drug License for 2 Days 19-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
20 Assistant Director,� Drugs Control Administration, Shameerpet,Telangana Suspension of drug license for 2 day from the date of receipt of order for sales premises 19-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
21 Drugs Control Administration, North Zone, Balaspore,Odisha Suspension of drug license for 3 day from the date of receipt of order for sales premises 22-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
22 Assistant Director, Drugs Control Administration, Rangareddy Dist,Telangana Suspension of drug license for 3 day from the date of receipt of order for sales premises 24-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
23 Assistant Director & District Sales Licencing & Enforcement Authority,Visakhapatnam,Anakapalli, And Alluri Seetharamaraju Districts,Andhra Pradesh Suspension of Drug License for 7days from the Date of Receipt 27.01.2026 to 02.02.2026 27-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
24 Assistant Director,� Drugs Control Administration, Patancheru,Telangana Suspension of drug license for 1 day from the date of receipt of order for sales premises 29-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
25 Asst. Commissioner & Licensing authority, Food & Drug Administations, MH, Bhandara,Maharashtra Suspension of Drug License for 25 days from 20.04.2026 to 14.05.2026 30-Jan-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
26 Asst. Commissioner & Licensing authority, Food & Drug Administrations, MH, PUNE Mr. R.V. PONGALE,Maharashtra Suspension of Drug License for 15 days from 27.04.2026 to 11.05.2026 03-Feb-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
27 Assistant Director, District sales licensing Authority,Drugs control Administration,Eluru , Eluru and West Godavari District,Andhra Pradesh Suspension of Drug License for 7 days from the Date of Receipt for sale permission/12-02-2026 to 18-10-2025 12-Feb-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
28 Assistant Director, Drugs Control Administration Tumkur Circle, Tumkur,Karnataka Suspension of Drug License for 1 day 19-Feb-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
29 Assistant Director, Drugs Control Administration, Davanagere Circle Davanagere,Karnataka Suspension of drug license for 5 days 20-Feb-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
30 Assistant Director, Drugs Control Administration, Davanagere Circle Davanagere,Karnataka Suspension of Drug License for 7 days 20-Feb-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
31 Assistant Director,� Drugs Control Administration, Shameerpet,Telangana Suspension of drug license for 3 days from the date of receipt of order for sales premises 22-Feb-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
32 Assistant Director, District sales licensing Authority,Drugs control Administration, Nagarampalem Guntur ,Guntur District,Andhra Pradesh Suspension of Drug License for 7 days from the Date of Receipt for sale permission/25-02-2026 to 03-03-2026 25-Feb-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
33 Assistant Director,� Drugs Control Administration, Rangareddy,Telangana Suspension of drug license for 1 day from the date of receipt of order for sales premises 27-Feb-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
34 Asst. Commissioner & Licensing authority, Food & Drug Administrations, MH, PUNE Mr. S.M.RATHOD,Maharashtra Suspension of Drug License for 7 days from 14.05.2026 to 20.05.2026 03-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
35 Licencsing Authority Deputy Drugs controller,Western zone,Sambalpur,Odisha. Suspension of Drug License for 3 days from 09.03.2026 to 11.03.2026 09-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
36 Assistant Director, Drugs Control Administration Bangalore South Circle Ramanagar,Karnataka Suspension of Drug License, 2 days 13-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
37 Assistant Director,� Drugs Control Administration, Rangareddy, Telangana Suspension of drug license for 3 days from the date of receipt of order for sales premises 13-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
38 The Assistant Director, Drugs control Administration,NTR & Krishna Districts ,Vijayawada, Andhra Pradesh Suspension of Drug License for 7 days from the Date of Receipt for sale permission/13-03-2026 to 19-03-2026 13-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
39 Assistant Director, Drugs Control Administration Bangalore South Circle Ramanagar, Karnataka Suspension of Drug License, 2 days 14-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
40 Assistant Director,Drugs Control Administration, Hubli Circle, Hubli, Karnataka Suspension of drug license for 5 days 16-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
41 The Assistant Director, Drugs control Administration,Eluru & West Godavari District, Andhra Pradesh Suspension of Drug License for 7 days from the Date of Receipt for sale permission/20-03-2026 to 26-03-2026 20-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
42 Assistant Director, Drugs Control Administration, Mandya Circle-Mandya Karnataka Suspension of Dug License for 3 days 21-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
43 Assistant Director,Drugs Control Administration, Hubli Circle, Hubli, Karnataka Suspension of Drug license for 3 days 27-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company
44 Assistant Director, Drugs Control Administration, Warangal, Telangana Suspension of drug license for 3 days from the date of receipt of order for sales premises 28-Mar-2026 Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 There is no material impact on financial, operations or other activities of the Company


Disclosure of Updates to Ongoing Tax Litigations or Disputes
The updates on tax litigations or disputes in terms of sub-para 8 of para B of Part A of Schedule III read with corresponding provisions of Annexure 18 of the Master Circular are given below:

Any Other Information for Disclosure of Updates to Ongoing Tax Litigations or Disputes
Sr. No. Name of the opposing party Date of initiation of the litigation / dispute Status of the litigation / dispute as per last disclosure Current status of the litigation / dispute
1 Income Tax Department, Assessment Unit 29-Dec-2022 Assessment Order U/s 143(3) on 29/12/22 for the AY:2021-22 received from Assessment Unit, Income Tax Department with a disputed tax amount of INR 3.48 Crores. We have filed an Appeal with CIT(A) against the Order of AO on 25/01/23. We have filed our written submission also. The Company is yet to receive hearing notice.
2 Income Tax Department, Assessment Unit 29-Dec-2022 Penalty Show Cause notice U/s 174 read with section 270A on 29/12/22 for the AY:2021-22 received from Assessment Unit, Income Tax Department for the outstanding demand. We have filed our reply against SCN on 08/02/23 saying that we have filed appeal with CIT(A) on 25/01/23 against the Order of AO. The Company is yet to receive hearing notice.
3 Income Tax Department 28-Feb-2015 Assessment Order U/s 143(3) on 28/02/15 for the AY:2012-13 received from ITO, Income Tax Department with disputed tax amount of INR 0.60 Crores. We have filed an Appeal with CIT(A) against the Order of AO on 06/05/15. After hearing we have received Appeal Order on 01/11/2019 with partly allowed. On 10/01/2020 we have filed Appeal with ITAT against the order of CIT(A). The case is remanded back to CIT(A) for further verification. The matter is pending from CIT(A).
4 Income Tax Department 31-Dec-2016 Assessment Order U/s 143(3) on 31/12/16 for the AY:2013-14 received from Assessing Officer, Income Tax Department with a disputed tax amount of INR 2.60 Crores. We have filed an Appeal with CIT(A) against the Order of AO on 15/02/17. We have submitted our written submissions. Order is awaiting. The matter is pending from CIT(A).
5 Income Tax Department 31-Dec-2019 Assessment Order U/s 143(3) on 31/12/19 for the AY:2017-18 received from Assessing Officer, Income Tax Department with a disputed tax amount of INR 8.30 Crores. We have filed an Appeal with CIT(A) against the Order of AO on 29/01/20. We have submitted our written submissions. Hearing date is yet to be received. The matter is pending from CIT(A).
6 Income Tax Department 29-Sep-2022 Assessment Order U/s 143(3) on 29/09/22 for the AY:2020-21 received from Assessing Officer, Income Tax Department with a disputed tax amount of INR 43.45 Crores. The Company filed a writ petition with Telangana High Court on 12/10/22. Hearing done partly and now further postponed to 11/02/25. Finally hearing done on 22/04/25 & 23/04/25 and the matter is reserved for the Order from the High Court. High Court Judgement came on 21/11/25 in fafour of the Company and our writ perition stands allowed by the High Court. But in December 2025, Department has filed review petition against the favourable order from the Court. We have filed counter affidavit against the review petition by the Department on 02/04/2026. High Court Judgement came on 21/11/25 in favour of the Company and our writ perition stands allowed by the High Court. But in December 2025, Department has filed review petition against the order from the Court. We have filed counter affidavit against the review petition by the Department on 02/04/2026. Hearing fixed for 09/04/26 but could not happen and further date of hearing is yet to come.
7 Sales Tax Officer, Bhubneshwar - 1 - Circle, Bhubneshwar, Odisha 28-May-2025 The Optival Health Solutions Private Limited (Subsidiary Company) has recevied an demand order of Rs. 21.48 Lacs towards tax liability for the Assessment: 01-04-2012 to 31.03.2014 (two years). The Company has filed an appeal before Joint Commissioner of Sales Tax, Bhubneshwar, Odisha on 25-05-2017 and the said authority pass a partly favorable order on 25.11.2017. The total demand amount was reduced to Rs. 7.32 Lacs. The Commissioner of Sales Tax, Bhubneshwar, Odisha also filed an appeal against the said order which is pending before the Tribunal. The matter is pending before the tribunal Odisha.
8 Deputy Commissoner of State Tax (LTU-1), PUNE_LTU-510, Pune, Maharashtra. 23-Feb-2024 The Optival Health Solutions Private Limted (Subsidiary Company) has recevied an demand order of Rs. 50.42 Lacs towards tax liability. The Company has filed an appeal before Joint Commissioner of State Tax (LTU-1), PUNE_LTU-510, Pune, Maharashtra on 23-05-2024. Further, Company had received unfavourable order from the first appellate authority vide Order ref no.ZD271225008476F Dt:02.12.2025 Demand Tax Rs.4268359/- Interst Rs.5849814/- and Penalty Rs.500975/- (Total Demand of Rs.10619148/-). Amount admitted against Point no.4 and 5 and paid through GST Cash ledger of Rs. 307,781/- (Tax 140,545/- Interest Rs.83,618/- and Penalty Rs.83,618/-) . Company seeking further appeal before appellate tribunal against impugned order for balance amount. The Joint Commissioner of State Tax (LTU-1), Pune, Maharashtra, vide Order No. ZD271225008476F dated 02.12.2025, determined the tax liability amounting to Rs. 42.70 lakhs.
9 Deputy Commissoner of State Tax (LTU-1), PUNE_LTU-510, Pune 16-Aug-2024 The Optival Health Solutions Private Limited (Subsidiary Company) has received an assessment order demanding Rs. 2,11,779,95/- (including tax Rs. 1,05,78,651, Interest Rs. 94,442,00 and Penalty Rs. 11,54,144) from Goods and Services Tax (GST) Department, Pune, Maharashtra for the assessment year 2019-20. ( Already Reported vide our letter 17.08.2024) The matter is pending before the Joint Commissioner of State Tax (LTU-1), Pune , Maharashtra.
10 Commercial Tax Officer, Audit-4.8), DGSTO-4, Bangalore-95. 04-Apr-2024 The Deccan Medisales Private Limted (Subsidiary Company) has recevied an order of Rs. 8,06,127 including (Interest & Penalty). The Company has filed an appeal before Joint Commissioner of State Tax Bangalore-95 on 02-07-2024. Further, First appellate authority had confirmed the demand for entire amount vide order ref no.ZD290725023361G Dt:07.07.2025, Company seeking further appeal before appellate tribunal against impugned order. The Appellate Joint Commissioner (ST), LGSTO 025 Bangaluru vide its order no. ZD290725023361G dated 07.07.2025 affirm the Demand order of Rs. 8,06,127 (tax liability amount of Rs. 4,06,030, Interest Rs. 3,39,597, Penalty of Rs. 60,500). Pursuant to the said appellate order, the Company has made an additional pre-deposit of Rs. 40,602 and is in the process of filing a second appeal before the Tribunal against the confirmed demand.
11 Office of the Asst. Commissioner of Commercial Taxes, LGSTO-025, Bangalore-95 19-Jul-2024 The Deccan Medisales Private Limted (Subsidiary Company) has recevied an order of Rs. 20,26,418. The Company has filed an appeal before Joint Commissioner of State Tax Bangalore-95 on 26-09-2024. Further, First appellate authority had confirmed the demand for entire amount vide order ref no.ZD2907250245348 Dt:07.07.2025,Company seeking further appeal before appellate tribunal against impugned order. The Appellate Joint Commissioner (ST), LGSTO 025 Bangaluru vide its order no. ZD2907250245348 dated 07.07.2025 affirm the Demand order of Rs. 20,26,418 (tax liability amount of Rs. 10,95,310, Interest Rs. 8,21,574, Penalty of Rs. 1,09,534). Pursuant to the said appellate order, the Company has made an additional pre-deposit of Rs. 1,09,532 and is in the process of filing a second appeal before the Tribunal against the confirmed demand.
12 Commercial Tax Officer, Jurisdiction: Kundrathur, Kancheepuram, TN 23-Dec-2025 Medplus Health Services Private Limited has received a demand order vide reference no. ZD331225357607B dated 23.12.2025 amounting to Rs. 8,87,210 pertaining to the financial year 2021-22, and the Company had filed theappeal before the first appellate authority agaisnt impugned order of adjudicating authority. The Company is in the process of filing an appeal before the appropriate appellate authority.
13 State Tax Officer, Jurisdiction Bhubaneswar I Circle, Odisha 23-Dec-2025 Optival Health Solutions Private Limited (Subsidiary Company) has received an order vide reference no. ZD211225029707L dated 23.12.2025 from the Odisha State authorities with NIL demand. The Order passed by the State Tax Officer, Jurisdiction Bhubaneswar I Circle, Odisha with NIL demand and the matter is closed.
14 Superendent of CGST, Range III, Khardah Division, Kolkata North Commissionerate 18-Feb-2026 Optival Health Solutions Private Limited had filed an appeal to The Commissioner CGST and CX, Kolkata as on May 25, 2023 and received the favorable order from first appellate authority,order amount of Rs.36,88,297/- on Feb 18, 2026, Further, GST Department filed an appeal before the Appellate Tribunal against the first appellate order ,having file number 2026061101000014 and case number 16/APL/2026. GST department filed an appeal before tribunal
15 Superendent of CGST, Range III, Khardah Division, Kolkata North Commissionerate 13-Feb-2026 Optival Health Solutions Private Limited had filed an appeal before the appealate authority Kolkata as on 2nd March2024 and received the favorable order from first appellate authority, order amount of Rs.65,90,636/- on Feb 18, 2026 Further, GST Department file an appeal before the Appellate Tribunal against the first appellate order , having file number 2026061101000010 and case number 13/APL/2026. GST department filed an appeal before tribunal
16 Superintendent, Jurisdiction: Ramanthapur, Amberpet, Secunderabad, TG 23-Dec-2025 Venkata Krishana Enterprises private Limited (Subsidiary Company) has received a demand order vide reference no. ZD361225087291D dated 23.12.2025 amounting to Rs. 8,47,847 pertaining to the financial year from 2021-22 to 2023-24, and the Company had filed the appeal before the first appellate authority agaisnt impugned order of adjudicating authority. The Company is in the process of filing an appeal before the appropriate appellate authority.
17 The Regional P.F. Commissioner- I, Pune-I, Employee Provident Fund Organisation (through Enforcement Officers) 31-Jan-2024 The Optival Health Solutions Private Limted (Subsidiary Company) has recevied an demand order of Rs. 1,88,96, 802/- (Rs. One Crore eighty eight lakhs ninety six thousand eight hundred two) for the period from 2017 to 2022 for violation of subsidy under EPF Scheme, 1952, read with 14B and 7Q to be deposited within 60 days of the order The matter is pending before the Central Goverment Industrial Tribunal (CGIT) Mumbai-2 Maharashtra and the next hearing scheduled on 18.05.2026.